Volume 20, Issue C, December 2017, Pages 35 - 43
Validation of non-invasive central blood pressure devices: Artery society task force (abridged) consensus statement on protocol standardization
Authors
James E. Sharman*
Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia
Alberto P. Avolio
Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
Johannes Baulmann
Clinic of Internal Medicine II, University Hospital Schleswig-Holstein, Luebeck, Germany
Athanase Benetos
Département de Médecine Gériatrique, CHRU de Nancy, INSERM U1116, Université de Lorraine, Vandoeuvre-les-Nancy, France
Jacques Blacher
Hypertension and Cardiovascular Prevention Unit, Hôtel-Dieu University Hospital, Assistance Publique-Hôpitaux de Paris, University Paris Descartes, Paris, France
C. Leigh Blizzard
Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia
Pierre Boutouyrie
Departments of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970 and University Paris Descartes, Paris, France
Chen-Huan Chen
Department of Medicine, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC
Phil Chowienczyk
Department of Clinical Pharmacology, King’s College London British Heart Foundation Centre, UK
John R. Cockcroft
Department of Biomedical Sciences, School of Health Sciences, Cardiff Metropolitan University, Cardiff, UK
J. Kennedy Cruickshank
Cardiovascular Medicine Group, Division of Diabetes and Nutritional Sciences, King’s College, London, UK
Isabel Ferreira
The University of Queensland, School of Public Health, Herston, Brisbane, Australia
Lorenzo Ghiadoni
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
Alun Hughes
Institute of Cardiovascular Science, University College London, UK
Piotr Jankowski
First Department of Cardiology and Hypertension, Institute of Cardiology, Jagiellonian University Medical College, Poland
Stephane Laurent
Departments of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970 and University Paris Descartes, Paris, France
Barry J. McDonnell
Department of Biomedical Sciences, School of Health Sciences, Cardiff Metropolitan University, Cardiff, UK
Carmel McEniery
Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, UK
Sandrine C. Millasseau
Pulse Wave Consulting, Saint Leu la Foret, France
Theodoros G. Papaioannou
Biomedical Engineering Unit, First Department of Cardiology, Hippokration Hospital, Medical School, National and Kapodistrian University of Athens, Greece
Gianfranco Parati
Department of Cardiology, S.Luca Hospital, Istituto Auxologico Italiano, Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Jeong Bae Park
Department of Medicine/Cardiology, Cheil General Hospital, Dankook University College of Medicine, Seoul, Republic of Korea
Athanase D. Protogerou
Cardiovascular Prevention and Research Unit, Department of Pathophysiology, ‘Laiko’ Hospital, Medical School, National and Kapodistrian University of Athens, Greece
Mary J. Roman
Division of Cardiology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA
Giuseppe Schillaci
Dipartimento di Medicina, Università di Perugia, Unità di Medicina Interna, Ospedale ‘S. Maria’, Terni, Italy
Patrick Segers
IBiTech-bioMMeda, Ghent University, Ghent, Belgium
George S. Stergiou
Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, Third Department of Medicine, Sotiria Hospital, Athens, Greece
Hirofumi Tomiyama
Department of Cardiology, Tokyo Medical University, Tokyo, Japan
Raymond R. Townsend
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Luc M. Van Bortel
Heymans Institute of Pharmacology, Ghent University, Ghent, Belgium
Jiguang Wang
The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Siegfried Wassertheurer
Austrian Institute of Technology, Health & Environment Department, Vienna, Austria
Thomas Weber
Cardiology Department, Klinikum Wels-Grieskirchen, Wels, Austria
Ian B. Wilkinson
Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, UK
Charalambos Vlachopoulos
First Department of Cardiology, Hippokration Hospital, Medical School, National and Kapodistrian University of Athens, Greece
*Corresponding author. Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia. E-mail address: james.sharman@utas.edu.au
Corresponding Author
James E. Sharman
Received 31 October 2017, Accepted 31 October 2017, Available Online 13 November 2017.
- DOI
- 10.1016/j.artres.2017.11.001How to use a DOI?
- Keywords
- Guideline; Aorta; Diagnostic equipment; Hypertension; Central blood pressure
- Abstract
Brachial cuff blood pressure (BP) is clinically important, but may be an inaccurate substitute for central BP. Many non-invasive devices have been developed that purport to estimate central BP from peripheral artery sites, yet with no standardized guidelines; the accuracy testing of these new devices has not been undertaken in a uniform fashion with comparable protocols. This is an abridged paper describing the recommendations reached by an international task force convened to identify issues that need to be addressed and reach consensus relating to methods for assessing and reporting the accuracy (validation) of central BP devices. The recommendations are endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society, as well as the European Society of Hypertension (ESH) Working Group on Arterial Structure and Function, and the ESH Working Group on Blood Pressure Monitoring and Cardiovascular Variability. Researchers interested in validating central BP monitors should read the full version of the statement.
- Copyright
- © 2017 Association for Research into Arterial Structure and Physiology. Published by Elsevier B.V. All rights reserved.
- Open Access
- This is an open access article distributed under the CC BY-NC license.
Download article (PDF)
View full text (HTML)
Cite this article
TY - JOUR AU - James E. Sharman AU - Alberto P. Avolio AU - Johannes Baulmann AU - Athanase Benetos AU - Jacques Blacher AU - C. Leigh Blizzard AU - Pierre Boutouyrie AU - Chen-Huan Chen AU - Phil Chowienczyk AU - John R. Cockcroft AU - J. Kennedy Cruickshank AU - Isabel Ferreira AU - Lorenzo Ghiadoni AU - Alun Hughes AU - Piotr Jankowski AU - Stephane Laurent AU - Barry J. McDonnell AU - Carmel McEniery AU - Sandrine C. Millasseau AU - Theodoros G. Papaioannou AU - Gianfranco Parati AU - Jeong Bae Park AU - Athanase D. Protogerou AU - Mary J. Roman AU - Giuseppe Schillaci AU - Patrick Segers AU - George S. Stergiou AU - Hirofumi Tomiyama AU - Raymond R. Townsend AU - Luc M. Van Bortel AU - Jiguang Wang AU - Siegfried Wassertheurer AU - Thomas Weber AU - Ian B. Wilkinson AU - Charalambos Vlachopoulos PY - 2017 DA - 2017/11/13 TI - Validation of non-invasive central blood pressure devices: Artery society task force (abridged) consensus statement on protocol standardization JO - Artery Research SP - 35 EP - 43 VL - 20 IS - C SN - 1876-4401 UR - https://doi.org/10.1016/j.artres.2017.11.001 DO - 10.1016/j.artres.2017.11.001 ID - Sharman2017 ER -